Literature DB >> 3960443

Chlamydia trachomatis infection in women with ectopic pregnancy.

R C Brunham, B Binns, J McDowell, M Paraskevas.   

Abstract

Fifty women with ectopic pregnancy and 49 control women with intrauterine pregnancy were interviewed and evaluated for evidence of Chlamydia trachomatis infection. Among women with ectopic pregnancy, 14 women were wearing an intrauterine contraceptive device or had a tubal ligation (group A), and 36 women had no readily identifiable risk factors (group B). Group B women had greater total numbers of sexual partners than did control women with intrauterine pregnancy (P less than .005). Group B women more often had C trachomatis antibody than group A (P = .03) and control women (P = .002). Of 27 C trachomatis cultures from fallopian tube tissue from women with ectopic pregnancy, none were positive. Fallopian tube tissue distant from the site of ectopic implantation was available for histopathology of 41 cases. Nine (22%) had extensive subepithelial plasma cell infiltration. All nine were among group B women (P = .06) and all seven with plasma cell salpingitis who were tested for C trachomatis antibody were seropositive (P = .004). It is concluded that a subset of women with ectopic pregnancy were at increased risk for acquiring a sexually transmitted disease by virtue of their sexual behavior and that women in this subset frequently have serologic evidence of C trachomatis infection and histologic evidence of plasma cell salpingitis. Because few of these women recall having had pelvic infection, the authors speculate that subclinical C trachomatis tubal infection producing plasma cell salpingitis may commonly underly ectopic pregnancy.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3960443     DOI: 10.1097/00006250-198605000-00022

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  24 in total

1.  Detection of Chlamydia trachomatis in urinary samples from women.

Authors:  L O Svensson; I Mares; S E Olsson
Journal:  Genitourin Med       Date:  1991-04

2.  Sexually transmitted infections.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-01       Impact factor: 2.471

3.  Pelvic inflammatory disease: a family practice perspective.

Authors:  J W Sellors
Journal:  Can Fam Physician       Date:  1989-06       Impact factor: 3.275

4.  Immunogenicity of a vaccine formulated with the Chlamydia trachomatis serovar F, native major outer membrane protein in a nonhuman primate model.

Authors:  Chunmei Cheng; Sukumar Pal; Ilham Bettahi; Kristie L Oxford; Peter A Barry; Luis M de la Maza
Journal:  Vaccine       Date:  2011-03-04       Impact factor: 3.641

5.  Prevalence of asymptomatic carriers of Chlamydia trachomatis among pregnant and non-pregnant women in south-western Greece.

Authors:  T Arkoulis; G Decavalas; M Papapetropoulou; J Detorakis; X Kondakis; V Tzigounis
Journal:  Eur J Epidemiol       Date:  1989-12       Impact factor: 8.082

6.  Endocervical Chlamydia trachomatis infection in Canadian adolescents.

Authors:  E G Hughes; J Mowatt; J E Spence
Journal:  CMAJ       Date:  1989-02-01       Impact factor: 8.262

7.  Protection against infertility in a BALB/c mouse salpingitis model by intranasal immunization with the mouse pneumonitis biovar of Chlamydia trachomatis.

Authors:  S Pal; T J Fielder; E M Peterson; L M de la Maza
Journal:  Infect Immun       Date:  1994-08       Impact factor: 3.441

8.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

9.  Fallopian tube obstruction as a sequela to Chlamydia trachomatis infection.

Authors:  M Kosseim; R C Brunham
Journal:  Eur J Clin Microbiol       Date:  1986-10       Impact factor: 3.267

Review 10.  Chlamydiae as pathogens--an overview of diagnostic techniques, clinical features, and therapy of human infections.

Authors:  A Oehme; P B Musholt; K Dreesbach
Journal:  Klin Wochenschr       Date:  1991-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.